Introduction
The literature on an apparent clinical association between diabetes mellitus, hyperthyroidism (Bowen and Lenzner, 1951; Breslau, Lashof and Klein, 1955; Ralli, Street and Pell, 1955) and hypothyroidism (Bernstein, 1948; Farrer-Brown, 1962; Mulhern, Mosi and Shulmann, 1965) is extensive. However, many of the earlier papers are only case reports and there are few series in which large groups of patients with thyroid disease and diabetes have been systematically evaluated in order to establish the magnitude of the association.
This report documents the frequency of the association of hyper-and hypothyroidism with diabetes mellitus as seen by one clinician (M.I.D.) at the Mater Hospital, Dublin, Ireland, over a 26-year period (Irvine, 1975 Irvine, 1975 . The demonstration of islet-cell antibodies in diabetics (Bottazzo, Florin-Christensen and Doniach, 1974) has led to the concept of distinct types of diabetes mellitus based on the presence or absence of autoimmune markers (MacCuish and Irvine, 1975) . A connection between tissue-type HLA-B8 and Graves' disease (Grumet et al., 1973; McKenna et al., 1981) has also been established and both thyroiditis and juvenile diabetes show a stronger association with HLA-B8 when they accompany other autoimmune disorders (Bottazzo et al., 1978 a,b) . Thus the earlier clinical observation of the association between dia- 16(14-2) 12(10-6) *n(%) The magnitude of the association is difficult to define. The incidence of overt hypothyroidism in different communities had varied from 0-6% (Reeve and Stewart, 1979) to 1-5% (Tunbridge et al., 1977) and the incidence of spontaneous primary hypothyroidism among the total admissions to several large hospitals was reported to be between 0.01% and 0.08% (Means, De Groot and Stanbury, 1963) .
Similarly, the reported incidence of diabetes mellitus has varied from 0.55% (Palumbo and Labarthe, 1978) to 0.8% (Medalie et al., 1975) . There is little reliable information on the prevalence of hyperthyroidism in the community. The inclusion of patients with subclinical hypothyroidism (Evered and Hall, 1972) inflates the magnitude of the association. The reported frequency of hypothyroidism and hyperthyroidism in patients with diabetes has varied from 0.7% to 4% (Baron, 1955; Hecht and Gershberg, 1968; Bridgman, 1971; Ganz and Kozak, 1974; Feely and Isles, 1979 ) and 3-2% to 4.6% (Regan and Wilder, 1940; Howard and Hayles, 1978) respectively (Tables  4 & 5) . It has been suggested that patients with diabetes mellitus should be screened routinely for evidence of thyroid dysfunction (Feely and Isles, 1979) .
The value of screening for evidence of subclinical thyroid dysfunction may be questioned, however, because raised TSH alone and the presence of thyroid antibodies alone does not increase the risk of subsequent overt hypothyroidism, and overt hypothyroidism develops at the rate of only 5% a year in women who have both raised TSH and thyroid antibodies (Tunbridge et al., 1981) . It might be more logical to screen only those patients with insulin dependent diabetes diagnosed before age 30, that is, those patients with a high prevalence of organspecific autoantibodies (Regan and Wilder, 1940; Howard and Hayles, 1978; Tunbridge et al., 1981; Irvine et al., 1970) .
Hunton, Wells and Skipper (1965) reported that treatment of diabetes with sulphonylureas led to an increased incidence of goitre and hypothyroidism. This view has subsequently been challenged (Ganz and Kozak, 1974; Prince, Worth and Shenfeld, 1980) and the discrepancy between results has been attributed to the greater goitrogenic potential of earlier sulphonylureas (Kuuisto and Antila, 1956) and their ability to reduce serum thyroid binding proteins (Burdick and Brice, 1968 (Althausen and Stockholm, 1938) and enhanced glucose-induced hyperinsulinism (Okajima and Ui, 1978) .
The importance of thyroid disease and diabetes mellitus ('thyrodiabetes') as a clinical entity must remain in considerable doubt. It is possible that the magnitude of the association is inflated because of the selected nature of the diabetic clinic population, although there is no reason to suspect that the patients who attend our clinic are in any way different from the total Irish diabetic population. Moreover, whilst the thyroid hormone profile is altered in uncontrolled diabetes with an increase in reverse T3 and decrease in serum T4 and T3 (Saunders, Hall and Sonsken, 1978) , neither hypoglycaemia nor ketoacidosis was a major problem in the present series and a dramatic change in insulin requirements did not occur at the onset of hyperthyroidism or hypothyroidism.
The incidence of early relapse (75%) among patients with hyperthyroidism and diabetes who were treated by carbimazole is higher than reported in previous series of non-diabetic hyperthyroid patients (Solomon et al., 1953; Hershman et al., 1966) . The 2-year and 10-year cumulative percentage relapse in 162 hyperthyroid patients treated by a 2-year course of carbimazole were 56% and 62% respectively (Sugrue et al., 1980 
